Beyond Elevation Book a Strategy Session
Patents

65% of Patents Die at the PTAB — The Inter Partes Review Defense Strategy Most Founders Discover Too Late

Hayat Amin
Hayat Amin CEO of Beyond Elevation · IP strategy & licensing
65% of Patents Die at the PTAB — The Inter Partes Review Defense Strategy Most Founders Discover Too Late

Your patent portfolio has a 65% kill rate hanging over it. Inter partes review — the PTAB proceeding that lets anyone challenge your patent's validity for a fraction of litigation cost — invalidates the majority of claims it examines. Yet fewer than 12% of startup founders have ever heard of IPR before receiving a petition.

Hayat Amin argues this is the single most dangerous blind spot in startup IP strategy: "Founders spend $30K to $80K filing patents and never once ask what happens when a well-funded competitor pays $30K to try to kill them at the PTAB. The asymmetry is staggering."

What Is an Inter Partes Review Defense Strategy?

An inter partes review defense strategy is a pre-built architecture of claim drafting, portfolio structuring, and prior art positioning that maximizes your patents' survival rate at the Patent Trial and Appeal Board (PTAB). It is not a response plan — it is a design principle baked into the portfolio from the first filing.

The PTAB was created by the America Invents Act in 2012 as a faster, cheaper alternative to district court for challenging patent validity. Anyone — a competitor, an NPE, a potential licensee seeking leverage — can file a petition requesting inter partes review of any claim in any granted patent. The filing fee starts at $23,000 for up to 20 claims. The proceeding finishes within 12 to 18 months. And the invalidation rate for claims that reach final written decision runs between 60% and 70%.

That is the threat model. An inter partes review defense strategy addresses it before the petition arrives, not after.

Why Inter Partes Review Is the Biggest Threat to Startup Patents

Inter partes review invalidates more startup-stage patents than litigation, design-arounds, and prosecution rejections combined. Since 2012, the PTAB has processed over 18,000 IPR petitions with a 60% to 65% institution rate and a 65% to 70% claim invalidation rate at final written decision — making IPR the most lethal challenge mechanism in the patent system.

For startups, the math is worse. Most startup portfolios contain 3 to 15 patents with claims drafted for breadth, not survivability. The typical patent attorney optimizes for prosecution — getting the patent granted — not for post-grant defense. Broad claims that pass the examiner are precisely the claims that fall at the PTAB, because broader claims have more prior art surface area.

Hayat Amin's view is blunt: "A patent attorney who drafts claims without modeling the IPR attack surface is building a house without a foundation. It looks solid until someone pushes."

The commercial consequences are direct. A single invalidated patent can collapse a licensing revenue model overnight. An IPR filed during due diligence can crater a fundraise or acquisition premium. And the cost of defending — $200K to $500K per proceeding — drains the exact capital a growth-stage company needs elsewhere.

The PTAB Survival Architecture: 5 Moves That Build Inter Partes Review Defense Into Your Portfolio

The PTAB Survival Architecture is the inter partes review defense strategy Hayat Amin developed after analyzing hundreds of IPR outcomes. It comprises five structural moves, each implemented during patent prosecution — not after a petition lands. Beyond Elevation applies this architecture to every new portfolio engagement.

Move 1: Draft Claims at Multiple Altitudes

File broad independent claims for licensing reach AND narrow dependent claims for IPR survivability. Narrow claims with specific structural limitations are harder to invalidate because they are harder to map to single prior art references that teach every element. Most patent attorneys draft 3 independent claims and 17 dependents. The PTAB Survival Architecture calls for 5 to 7 independent claims at different breadth levels and 13 to 15 dependents that add increasingly specific limitations. When the broad claims fall — and at the PTAB, broad claims frequently fall — the narrow claims survive and preserve your licensing position.

Move 2: Build a Continuation Chain

A continuation strategy is the backbone of any inter partes review defense. File at least one continuation application before the parent patent grants. This gives you a pending application with the same priority date that can be amended in response to the PTAB's claim construction — something you cannot do with an already-granted patent under IPR. The continuation is your escape hatch: if the PTAB construes your claims in a way that opens them to prior art, you draft new claims in the continuation that thread the needle between the Board's construction and the prior art.

Move 3: Maintain Trade Secret Fallbacks

Not every innovation should be patented. The trade-off is disclosure: a patent publishes your technique to the world. If the PTAB invalidates the claims, you have published the recipe and lost the legal protection simultaneously. For innovations where detection by competitors is difficult — internal algorithms, training pipelines, manufacturing process parameters — a trade secret provides indefinite protection with zero IPR exposure. Hayat Amin's rule: "If a competitor cannot reverse-engineer it from your product, do not give them the publication for free by patenting it."

Move 4: Portfolio Redundancy Through Patent Clustering

A single patent is a single point of failure. Patent clustering — filing multiple patents that cover the same product feature from different technical angles — creates redundancy that no single IPR petition can eliminate. If a competitor invalidates Patent A's claims on the data processing method, Patents B through D still cover the user interface implementation, the system architecture, and the data structure. Invalidating the entire cluster requires multiple IPR petitions, each costing $23K+ in filing fees and $200K to $500K in legal costs. The economics shift in the patent holder's favor.

Move 5: Pre-Petition Prior Art Audit

Before a competitor finds the prior art that kills your claims, find it yourself. A pre-petition prior art audit maps every piece of prior art that could be used against each independent claim. This audit reveals which claims are vulnerable and which are resilient. Vulnerable claims get proactively narrowed through reexamination or reissue. Resilient claims get documented with a pre-prepared defense dossier — claim charts showing every distinction from the closest prior art — so that when a petition arrives, the response is drafted from a prepared position, not a panicked scramble.

Hayat Amin reminds founders that this audit costs $15K to $40K. Defending an IPR petition without preparation costs $200K to $500K. The ROI is 10x before the petition even arrives.

What Happens When You Receive an Inter Partes Review Petition

When an inter partes review petition lands, the clock starts immediately. The patent owner has 3 months from institution to file a preliminary response — and the quality of that response largely determines the outcome. Without pre-positioned defense materials, most startups scramble to assemble a response team while burning through capital.

Month 0 to 3 (pre-institution): The PTAB reviews the petition and decides whether to institute review. The patent owner can file a preliminary response arguing against institution. Cost: $50K to $100K.

Month 3 to 12 (discovery and briefing): If instituted, both sides conduct limited discovery, file expert declarations, and submit briefs. The patent owner can amend claims through a motion to amend, though the PTAB grants fewer than 25% of these motions. Cost: $150K to $350K.

Month 12 to 18 (oral hearing and final written decision): The PTAB conducts an oral hearing and issues a final written decision on every challenged claim. The decision is appealable to the Federal Circuit. Cost: $50K to $100K additional.

Total cost of a fully contested IPR defense: $200K to $500K. Total timeline: 12 to 18 months. That is faster and cheaper than district court litigation — which is exactly why competitors use it.

The Founders Who Survive the PTAB Build the Portfolio Differently

An inter partes review defense strategy is not something you bolt on after receiving a petition. It is embedded in the portfolio's DNA from the first provisional filing. The founders who build stress-tested portfolios — with multi-altitude claims, continuation chains, trade secret fallbacks, cluster redundancy, and pre-audited prior art — are the founders whose patents survive the PTAB and continue generating recurring licensing revenue.

Hayat Amin says the test is simple: "Run an IPR simulation on your top 3 patents before your next board meeting. If the simulation kills more than one claim per patent, your portfolio is a liability, not an asset."

At Beyond Elevation, every portfolio engagement starts with the PTAB threat model. The goal is not just a granted patent — it is a patent that survives the hardest challenge the system allows. That is the difference between IP as a line item and IP as a competitive weapon.

Book a consultation at beyondelevation.com to stress-test your portfolio against the PTAB before a competitor does it for you.

FAQ

How long does an inter partes review take?

An inter partes review takes 12 to 18 months from petition filing to final written decision. The PTAB has a statutory deadline of 12 months from institution, with a possible 6-month extension. Including the pre-institution phase, the entire proceeding runs 15 to 21 months end-to-end.

How much does it cost to defend against an IPR petition?

Defending a fully contested inter partes review typically costs $200K to $500K in legal fees, expert witness costs, and associated expenses. A preliminary response alone costs $50K to $100K. These costs make pre-petition defense architecture — building IPR-resilient claims from the outset — the more capital-efficient approach for startups.

Can you amend patent claims during an inter partes review?

The patent owner can file a motion to amend claims during inter partes review. However, the PTAB grants fewer than 25% of motions to amend. The applicant must propose substitute claims and demonstrate that they are patentable over all prior art — a high bar. This is why the continuation chain in the PTAB Survival Architecture is critical: a pending continuation allows claim amendments outside the restrictive IPR amendment process.

Who can file an inter partes review petition?

Any person or entity that is not the patent owner can file an IPR petition, as long as they have not previously filed a civil action challenging the patent's validity. Competitors, potential licensees, NPEs, and anonymous third parties can petition. The one-year time limit applies: a petition must be filed within one year of being served with an infringement complaint asserting that patent.

What is the invalidation rate at the PTAB?

The PTAB invalidates approximately 65% to 70% of claims that reach final written decision in inter partes review. When including partial invalidation, the rate of at least some claims being invalidated exceeds 80%. This rate makes IPR the most effective patent-challenge mechanism available and underscores why a proactive inter partes review defense strategy is essential for any patent holder.